| Identification | Back Directory | [Name]
BTK inhibitor 13 | [CAS]
2376726-26-8 | [Synonyms]
BTK inhibitor 13
BTK INHIBITOR 13 (COMPOUND 8)
Benzamide, 4-cyclopropyl-N-[5-fluoro-2-methyl-3-[5-[2-[methyl(1-oxo-2-propen-1-yl)amino]acetyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]phenyl]- | [Molecular Formula]
C29H26FN5O3 | [MDL Number]
MFCD32263054 | [MOL File]
2376726-26-8.mol | [Molecular Weight]
511.55 |
| Hazard Information | Back Directory | [Uses]
BTK inhibitor 13 (compound 8) is a potent and selective Bruton's tyrosine kinase (BTK) inhibitor with an IC50 of 1.2 nM[1]. | [References]
[1] Pulz R, et al. Design of Potent and Selective Covalent Inhibitors of Bruton's Tyrosine Kinase Targeting an Inactive Conformation. ACS Med Chem Lett. 2019 Sep 6;10(10):1467-1472. DOI:10.1021/acsmedchemlett.9b00317 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
|